Gini Deshpande, PhD, leverages her scientific training and business acumen to turn ground-breaking technologies into products that benefit patients. She has built and led global, diverse teams to accomplish important business objectives. She founded NuMedii, a next generation biopharma company that pioneered the use of artificial intelligence and advanced data sciences to rapidly discover new precision therapeutics. As CEO, she raised financing from top tier VC firms, structured critical partnerships with several large pharma companies and is spearheading the company’s transition as it develops its own pipeline. Previously, she helped Affymetrix and other companies with market development strategies for their innovative technologies. She led intrapreneurial efforts at Children’s Hospital Boston for the creation of new devices for the tiniest of patients and vaccines for the developing world. Gini has also helped commercialize early stage life sciences technologies in research tools, diagnostics & therapeutics and has closed licensing deals worth several million. Gini received her MS from the University of Pune (India), her PhD in Biological Sciences from Purdue University, and did post-doctoral work at Massachusetts General Hospital. She is passionate about supporting women in STEM and enjoys being a mentor to women entrepreneurs and scientists.
Founder & CEO